08 Jun 2021 OXURION completes patient enrollment for Part A of Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME) Member news
02 Jun 2021 RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV Member news
20 May 2021 Eurofins Genomics meets global demand for SARS-CoV-2 full genome sequencing, with over 100,000 sequenced samples in less than 8 weeks Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us